Novo Nordisk Forecast, price target & analysts
Novo Nordisk Target price 2025 - Analyst rating & recommendation
Novo Nordisk Classifications & Recommendation:
Novo Nordisk Price Target
| Target Price | DKK632.40 |
| Price | DKK308.80 |
| Potential |
104.79%
register free of charge
|
| Number of Estimates | 28 |
|
28 Analysts have issued a price target Novo Nordisk 2026 .
The average Novo Nordisk target price is DKK632.40.
This is
104.79%
register free of charge
DKK945.00
206.02%
register free of charge
DKK409.05
32.46%
register free of charge
|
|
| A rating was issued by 31 analysts: 17 Analysts recommend Novo Nordisk to buy, 12 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Novo Nordisk stock has an average upside potential 2026 of
104.79%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion DKK | 290.40 | 330.82 |
| 25.03% | 13.92% | |
| EBITDA Margin | 48.98% | 51.36% |
| 6.29% | 4.85% | |
| Net Margin | 34.78% | 36.35% |
| 3.48% | 4.53% |
26 Analysts have issued a sales forecast Novo Nordisk 2025 . The average Novo Nordisk sales estimate is
This results in the following potential growth metrics:
23 Analysts have issued an Novo Nordisk EBITDA forecast 2025. The average Novo Nordisk EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
26 Novo Nordisk Analysts have issued a net profit forecast 2025. The average Novo Nordisk net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share DKK | 22.63 | 27.09 |
| 21.54% | 19.71% | |
| P/E | 11.40 | |
| EV/Sales | 4.45 |
26 Analysts have issued a Novo Nordisk forecast for earnings per share. The average Novo Nordisk EPS is
This results in the following potential growth metrics and future valuations:
Current Novo Nordisk Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BERENBERG |
Locked
➜
Locked
|
Locked | Jul 14 2025 |
| ROTHSCHILD & CO REDBURN |
Locked
➜
Locked
|
Locked | Jul 14 2025 |
| TD COWEN |
Locked
➜
Locked
|
Locked | Jul 13 2025 |
| GUGGENHEIM SECURITIES LLC |
Locked
➜
Locked
|
Locked | Jul 10 2025 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Jun 22 2025 |
| CRISPIDEA PRIVATE LIMITED |
Locked
➜
Locked
|
Locked | May 26 2025 |
| HSBC |
Locked
➜
Locked
|
Locked | May 25 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
BERENBERG:
Locked
➜
Locked
|
Jul 14 2025 |
|
Locked
ROTHSCHILD & CO REDBURN:
Locked
➜
Locked
|
Jul 14 2025 |
|
Locked
TD COWEN:
Locked
➜
Locked
|
Jul 13 2025 |
|
Locked
GUGGENHEIM SECURITIES LLC:
Locked
➜
Locked
|
Jul 10 2025 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Jun 22 2025 |
|
Locked
CRISPIDEA PRIVATE LIMITED:
Locked
➜
Locked
|
May 26 2025 |
|
Locked
HSBC:
Locked
➜
Locked
|
May 25 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
